HK1203370A1 - Method for treatment of labor arrest - Google Patents

Method for treatment of labor arrest Download PDF

Info

Publication number
HK1203370A1
HK1203370A1 HK15103909.7A HK15103909A HK1203370A1 HK 1203370 A1 HK1203370 A1 HK 1203370A1 HK 15103909 A HK15103909 A HK 15103909A HK 1203370 A1 HK1203370 A1 HK 1203370A1
Authority
HK
Hong Kong
Prior art keywords
treatment
labor
arrest
labor arrest
sulfated glycosaminoglycans
Prior art date
Application number
HK15103909.7A
Other languages
English (en)
Chinese (zh)
Inventor
‧埃克曼-奧德貝格
G‧埃克曼-奥德贝格
‧馬爾姆斯特倫
A‧马尔姆斯特伦
Original Assignee
迪乐方有限责任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 迪乐方有限责任公司 filed Critical 迪乐方有限责任公司
Publication of HK1203370A1 publication Critical patent/HK1203370A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HK15103909.7A 2012-03-26 2013-03-25 Method for treatment of labor arrest HK1203370A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615400P 2012-03-26 2012-03-26
US61/615,400 2012-03-26
PCT/SE2013/050333 WO2013147690A1 (en) 2012-03-26 2013-03-25 Method for treatment of labor arrest

Publications (1)

Publication Number Publication Date
HK1203370A1 true HK1203370A1 (en) 2015-10-30

Family

ID=49260784

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103909.7A HK1203370A1 (en) 2012-03-26 2013-03-25 Method for treatment of labor arrest

Country Status (15)

Country Link
US (1) US20150057226A1 (https=)
EP (1) EP2830634A4 (https=)
JP (1) JP2015514705A (https=)
CN (1) CN104244957B (https=)
AU (1) AU2013240598A1 (https=)
CA (1) CA2868479A1 (https=)
HK (1) HK1203370A1 (https=)
MX (1) MX2014011451A (https=)
MY (1) MY185108A (https=)
NZ (1) NZ631279A (https=)
RU (1) RU2014143008A (https=)
SG (1) SG11201406118QA (https=)
UA (1) UA117907C2 (https=)
WO (1) WO2013147690A1 (https=)
ZA (1) ZA201406567B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104144950B (zh) 2011-12-19 2017-09-05 迪乐方有限责任公司 含有重复的二糖单元的非抗凝的葡糖胺聚糖及其医药用途
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
EP3431092A1 (en) 2012-03-26 2019-01-23 Santen Pharmaceutical Co., Ltd. Ophthalmic solution comprising diquafosol
JP2015516415A (ja) * 2012-05-08 2015-06-11 ディラフォール・アクチボラゲットＤｉｌａｆｏｒ Ａｂ 化学修飾ヘパリンまたはヘパラン硫酸および子宮収縮剤を用いた分娩後出血の処置
JP7621366B2 (ja) 2020-02-17 2025-01-24 ディラフォール アクチエボラグ 子癇前症の処置のためのタフォキシパリン
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin
AU2023266079A1 (en) 2022-05-03 2024-10-31 Dilafor Ab New medical use of tafoxiparin
AU2024213271A1 (en) * 2023-02-01 2025-07-17 Materna Medical, Inc. Methods and apparatus for preventing vaginal lacerations during childbirth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000065837A (ja) * 1998-08-24 2000-03-03 Seikagaku Kogyo Co Ltd グリコサミノグリカン又はグリコサミノグリカン結合性分子の測定方法及びその測定用キット
JP2000309544A (ja) * 1999-02-25 2000-11-07 Seikagaku Kogyo Co Ltd 早産または流産防止剤および子宮頚管熟化抑制剤ならびにヒアルロニダーゼの阻害剤
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
WO2009073184A1 (en) * 2007-12-03 2009-06-11 Florida State University Research Foundation, Inc. Compositions for inducing labor and associated methods
CN104144950B (zh) * 2011-12-19 2017-09-05 迪乐方有限责任公司 含有重复的二糖单元的非抗凝的葡糖胺聚糖及其医药用途

Also Published As

Publication number Publication date
WO2013147690A1 (en) 2013-10-03
JP2015514705A (ja) 2015-05-21
MX2014011451A (es) 2014-11-10
EP2830634A1 (en) 2015-02-04
CN104244957A (zh) 2014-12-24
ZA201406567B (en) 2017-06-28
RU2014143008A (ru) 2016-05-20
EP2830634A4 (en) 2016-01-20
UA117907C2 (uk) 2018-10-25
AU2013240598A1 (en) 2014-10-02
CN104244957B (zh) 2017-11-17
MY185108A (en) 2021-04-30
US20150057226A1 (en) 2015-02-26
SG11201406118QA (en) 2014-11-27
NZ631279A (en) 2016-06-24
CA2868479A1 (en) 2013-10-03

Similar Documents

Publication Publication Date Title
HK1203370A1 (en) Method for treatment of labor arrest
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
IL235446A0 (en) Methods for treating diabetic retinopathy and other eye diseases
WO2015003360A3 (en) Therapeutically active compounds and their methods of use
HK1203356A1 (en) Pharmaceutical combinations comprising a thionucleotide analog
WO2012121977A3 (en) Dodecafluoropentane emulsion as a stroke and ischemia therapy
WO2013185764A3 (en) Pharmaceutical compositions for combination therapy
HK1223924A1 (zh) 治疗活性化合物及其使用方法
IL238800B (en) Immunomodulatory compounds and drugs containing them for use in the treatment of allergic diseases and other inflammatory conditions, infectious diseases and cancer
WO2013117744A3 (en) Methods of treating fibrosis
HK1226308A1 (zh) 使用白细胞介素-10治疗疾病和病症的方法
WO2014153009A3 (en) Thiosaccharide mucolytic agents
EP3318879A4 (en) Gpc3-targeted therapeutic agent administered to patient in whom gpc3-targetd therapeutic ag
GB2497453B (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
CL2013003700A1 (es) Composicion farmaceutica oftalmologica topica que comprende regorafenib, el cual se encuentra suspendido en un vehiculo farmaceuticamente aceptable; procedimiento de fabricacion y su uso para tratar o prevenir un trastorno oftalmologico.
WO2014153385A3 (en) Methods of treating metabolic disorders
HK1203369A1 (en) Combination treatment comprising sulphated glycosaminoglycans for inducing labor
IL236637A (en) Diploorulctam Compounds as selective ep4 receptor agonists for use in ep4-mediated diseases and conditions
EP2818154A4 (en) TOPICAL PREPARATION FOR SKIN AND CELL ACTIVATION AGENT FOR HEALTHY SKIN
EP3265060A4 (en) Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent
SI3125865T1 (sl) Povezava aktivnih sestavin za lokalno uporabo pri prestrukturiranju spremenjene kožne pregrade ki sledi kožnim boleznim
WO2015063613A3 (en) Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
WO2013176877A3 (en) Treatment of addiction and impulse-control disorders using pde7 inhibitors
IN2014MN02461A (https=)
MY192330A (en) Treatment of postpartum haemorrhage with chemically modified heapin or heparan sulphate and a uterotonic agent